These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 20981593)
61. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer. Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501 [TBL] [Abstract][Full Text] [Related]
62. Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience. Li F; Nielsen G; Baran A; Hu J; Wallace D; Preslar M; Fleming F; Temple L; Dunne RF; Noel M; Hezel AF; Tejani MA Clin Colorectal Cancer; 2020 Sep; 19(3):e124-e128. PubMed ID: 32409226 [TBL] [Abstract][Full Text] [Related]
63. Survival of rectal cancer in Yazd, Iran. Akhavan A; Binesh F; Soltani A Asian Pac J Cancer Prev; 2014; 15(12):4857-60. PubMed ID: 24998553 [TBL] [Abstract][Full Text] [Related]
64. Neoadjuvant therapy does not affect lymph node ratio in rectal cancer. Chang KH; Kelly NP; Duff GP; Condon ET; Waldron D; Coffey JC Surgeon; 2016 Oct; 14(5):270-3. PubMed ID: 26148760 [TBL] [Abstract][Full Text] [Related]
66. Impact of microscopic extranodal tumor deposits on the outcome of patients with rectal cancer. Prabhudesai A; Arif S; Finlayson CJ; Kumar D Dis Colon Rectum; 2003 Nov; 46(11):1531-7. PubMed ID: 14605575 [TBL] [Abstract][Full Text] [Related]
67. Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy. Tsutsumi S; Tabe Y; Fujii T; Yamaguchi S; Suto T; Yajima R; Morita H; Kato T; Shioya M; Saito J; Asao T; Nakano T; Kuwano H Anticancer Res; 2011 Nov; 31(11):3963-7. PubMed ID: 22110227 [TBL] [Abstract][Full Text] [Related]
68. Preoperative staging of irradiated rectal cancers using digital rectal examination, computed tomography, endorectal ultrasound, and magnetic resonance imaging does not accurately predict T0,N0 pathology. Kahn H; Alexander A; Rakinic J; Nagle D; Fry R Dis Colon Rectum; 1997 Feb; 40(2):140-4. PubMed ID: 9075746 [TBL] [Abstract][Full Text] [Related]
69. Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer? Hur H; Kim NK; Min BS; Baik SH; Lee KY; Koom WS; Ahn JB; Kim H Dis Colon Rectum; 2014 May; 57(5):592-601. PubMed ID: 24819099 [TBL] [Abstract][Full Text] [Related]
70. Analysis of 830 cases of rectal adenocarcinoma. 1. Progressively improved results of treatment. Thomas WH; Larson RA; Wright HK; Cleveland JC Conn Med; 1969 Sep; 33(9):569-70. PubMed ID: 5823555 [No Abstract] [Full Text] [Related]
71. Prognostic value of pathological node status after neoadjuvant radiotherapy for rectal cancer. Duchalais E; Glyn Mullaney T; Spears GM; Kelley SR; Mathis K; Harmsen WS; Larson DW Br J Surg; 2018 Oct; 105(11):1501-1509. PubMed ID: 29663352 [TBL] [Abstract][Full Text] [Related]
72. Impact of perineural and lymphovascular invasion on oncological outcomes in rectal cancer treated with neoadjuvant chemoradiotherapy and surgery. Cienfuegos JA; Rotellar F; Baixauli J; Beorlegui C; Sola JJ; Arbea L; Pastor C; Arredondo J; Hernández-Lizoáin JL Ann Surg Oncol; 2015 Mar; 22(3):916-23. PubMed ID: 25190129 [TBL] [Abstract][Full Text] [Related]
73. Outcome of rectal cancer in patients aged 30 years or less in the Pakistani population. Akbar A; Bhatti AB; Khattak S; Syed AA; Kazmi AS; Jamshed A Asian Pac J Cancer Prev; 2014; 15(15):6339-42. PubMed ID: 25124621 [TBL] [Abstract][Full Text] [Related]
74. The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy. Zhang LN; Xiao W; OuYang PY; You K; Zeng ZF; Ding PR; Pan ZZ; Xu RH; Gao YH Tumour Biol; 2015 Sep; 36(10):8213-9. PubMed ID: 25994571 [TBL] [Abstract][Full Text] [Related]
75. Prognosis in colon cancer: a pathologic reassessment. Murray D; Hreno A; Dutton J; Hampson LG Arch Surg; 1975 Aug; 110(8):908-13. PubMed ID: 1156157 [TBL] [Abstract][Full Text] [Related]
76. Outcome standards for an organ preservation strategy in stage II and III rectal adenocarcinoma after neoadjuvant chemoradiation. Wolthuis AM; Penninckx F; Haustermans K; Ectors N; Van Cutsem E; D'Hoore A Ann Surg Oncol; 2011 Mar; 18(3):684-90. PubMed ID: 20842458 [TBL] [Abstract][Full Text] [Related]
77. Endocavitary irradiation in the curative treatment of early rectal cancers. Papillon J Dis Colon Rectum; 1974; 17(2):172-80. PubMed ID: 4362114 [No Abstract] [Full Text] [Related]
78. Thyroid metastasis from rectal adenocarcinoma. Amante MA; Real IO; Bermudez G BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30108119 [TBL] [Abstract][Full Text] [Related]
79. Role of biopsies in patients with residual rectal cancer following neoadjuvant chemoradiation after downsizing: can they rule out persisting cancer? Perez RO; Habr-Gama A; Pereira GV; Lynn PB; Alves PA; Proscurshim I; Rawet V; Gama-Rodrigues J Colorectal Dis; 2012 Jun; 14(6):714-20. PubMed ID: 22568644 [TBL] [Abstract][Full Text] [Related]
80. Delay to Adjuvant Chemotherapy: Survival and Recurrence in Patients of Rectal Cancer Treated with Neo-adjuvant Chemoradiotherapy and Surgery. Thong DW; Kim J; Naik A; Lu CT; Nolan GJ; Von Papen M J Gastrointest Cancer; 2020 Sep; 51(3):877-886. PubMed ID: 31691086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]